@Yale_CRIT


Yale_CRIT
@Yale_CRIT -
Dec 12

New policy paper urges governments to ensure that patients, doctors, and scientists can access the full results of all clinical trials. https://t.co/sabV9e5CnB

Yale_CRIT
@Yale_CRIT -
Dec 11

Interested in working on projects related to pharmaceutical policy and law? @PORTAL_Research at Harvard Med is looking for postdoctoral fellows to work with @akesselheim, @AmeetSarpatwari and the growing PORTAL team. See link: https://t.co/euDkEtbwSZ https://t.co/vsHt3itWXv

Yale_CRIT
@Yale_CRIT -
Dec 7

RT @jsross119: Reports on our recently published study on drug maker disclosure of clinical trial data supporting 2014 FDA approvals: media…

Yale_CRIT
@Yale_CRIT -
Dec 7

RT @JoshuaDWallach: It seems like the "#Reproducibility crisis" has turned into a "reproducibility hostage" situation?

https://t.co/EMmDAY…

Yale_CRIT
@Yale_CRIT -
Dec 5

RT @JoshuaDWallach: High levels of #transparency found among large pharmaceutical companies and newly approved drugs for trials conducted i…

CRIT Program Mission Statement


To promote health by improving the integrity and transparency of biomedical and clinical research

About the CRIT Program


The Collaboration for Research Integrity and Transparency (CRIT) is an inter-disciplinary initiative launched in 2016 to enhance the quality and transparency of the research base for medical products. Through research, advocacy, and litigation, CRIT is focused on ensuring that the clinical evidence that supports and informs our understanding of the safety and effectiveness of pharmaceuticals, medical devices, and other medical products is accurate, comprehensive, accessible, and reliable. The lack of transparency and integrity in clinical research has had serious consequences for patient and clinicians. Current legal structures and research practices are not adequate and efforts to understand and improve clinical research transparency and reporting are needed.

By influencing stakeholders engaged in the clinical research process and in translating these findings for clinical care, CRIT will focus and magnify the impact of our and others’ scholarship, policy analysis and legal action, advancing the field of research integrity, open science, and informing public discourse.

CRIT aims to

  • Achieve a legal and regulatory environment that promotes rigorous clinical research and supports regulatory and clinical decisions that are grounded in high-quality research and accessible data and results.
  • Strengthen the integrity of research of medical products by ensuring that data is both rigorous and reliable, and by facilitating public access to and independent analysis of clinical trial data and results.
  • Conduct legal, public health and health policy research that identifies strengths and weakness of our existing system for facilitating evidence generation and transparency, and developing and evaluating alternative approaches
  • Provide the public and key policymakers with tools that enhance and facilitate open access to data, research results, and other relevant information about medical products.

Funding

 

Contact Katherine Lawton at [email protected] if you are interested in joining our email list 

Contact Us


For more information or to join our mailing list, contact Katherine Lawton, Program Coordinator, at [email protected] or call (203) 436-8420

Mailing Address:

c/o Yale Law School
Collaboration for Research Integrity & Transparency
157 Church Street 17th Floor
New Haven, CT 06510-2100

 

Follow us on Twitter

Like us on Facebook